Though low cost cards can help relieve the stress of significant drug expenses while in the temporary, they don't deal with the systemic issues driving up prescription charges while in the U.S. Broader policy improvements could tackle the foundation causes of mounting drug rates, which include insufficient transparency in pricing as well as part of